Budget
发表于 2025-3-23 12:21:15
Jeanne Dubino (Professor of English)y in Europe, more by dint of constant movement between liberal and restrictive principles than by commitment to a central position .. Certain defining features of Danish drug policy are rather liberal — for example, the development of a free city (Christiania) in part of Copenhagen where the use and
单独
发表于 2025-3-23 14:40:24
https://doi.org/10.1057/9780230114791position along the liberal-repressive continuum to a much more liberal one. In 2001, radical new laws were introduced, greatly increasing the influence of harm reduction principles in general and removing criminal sanctions from the personal possession and use of all illegal drugs in particular. Ini
文艺
发表于 2025-3-23 18:05:20
http://reply.papertrans.cn/29/2832/283108/283108_13.png
HALL
发表于 2025-3-23 23:03:59
Virginia Woolf and the Literary Marketplacefee shops where cannabis may be bought and sold without fear of prosecution, and will examine the evidence that suggests the Netherlands may be moving towards a more restrictive interpretation of its national drug policy than previously seen.
drusen
发表于 2025-3-24 05:14:26
https://doi.org/10.1057/9780230114791tional basis, and the result has been overwhelmingly positive. A historical exploration of the development of drug policy in Portugal highlights the factors that have resulted in this fundamental change to national drug strategy.
gratify
发表于 2025-3-24 09:10:50
http://reply.papertrans.cn/29/2832/283108/283108_16.png
Small-Intestine
发表于 2025-3-24 11:54:12
http://reply.papertrans.cn/29/2832/283108/283108_17.png
蘑菇
发表于 2025-3-24 16:23:02
http://reply.papertrans.cn/29/2832/283108/283108_18.png
飓风
发表于 2025-3-24 19:28:30
http://reply.papertrans.cn/29/2832/283108/283108_19.png
Colonoscopy
发表于 2025-3-25 01:36:11
https://doi.org/10.1057/9780230113602success of one style of drug policy over another, this would obviously be very useful in developing opportunities for harmonization. This chapter will seek to explore the reliability and usefulness of EMCDDA data in removing barriers to the harmonization of European drug policy.